A 4-aminobenzoic acid derivative as novel lead for selective inhibitors of multidrug resistance-associated proteins

2008 ◽  
Vol 18 (17) ◽  
pp. 4761-4763 ◽  
Author(s):  
Stefan Leyers ◽  
Hans-Georg Häcker ◽  
Jeanette Wiendlocha ◽  
Michael Gütschow ◽  
Michael Wiese
ChemInform ◽  
2009 ◽  
Vol 40 (1) ◽  
Author(s):  
Stefan Leyers ◽  
Hans-Georg Haecker ◽  
Jeanette Wiendlocha ◽  
Michael Guetschow ◽  
Michael Wiese

2006 ◽  
Vol 71 (10) ◽  
pp. 1470-1478 ◽  
Author(s):  
J.M. Maher ◽  
X. Cheng ◽  
Y. Tanaka ◽  
G.L. Scheffer ◽  
C.D. Klaassen

2011 ◽  
Vol 39 (7) ◽  
pp. 1294-1302 ◽  
Author(s):  
Hanneke G. M. Wittgen ◽  
Jeroen J. M. W. van den Heuvel ◽  
Petra H. H. van den Broek ◽  
Heike Dinter-Heidorn ◽  
Jan B. Koenderink ◽  
...  

2007 ◽  
Vol 560 (2-3) ◽  
pp. 127-131 ◽  
Author(s):  
Tullia Diena ◽  
Raffaella Melani ◽  
Emanuela Caci ◽  
Nicoletta Pedemonte ◽  
Elvira Sondo ◽  
...  

Pharmaceutics ◽  
2019 ◽  
Vol 11 (11) ◽  
pp. 593 ◽  
Author(s):  
Jaeok Lee ◽  
Song Wha Chae ◽  
LianJi Ma ◽  
So Yeon Lim ◽  
Sarah Alnajjar ◽  
...  

P-glycoprotein (P-gp) is known to be involved in multidrug resistance (MDR) and modulation of pharmacokinetic (PK) profiles of substrate drugs. Here, we studied the effects of synthesized ferulic acid (FA) derivatives on P-gp function in vitro and examined PK alteration of paclitaxel (PTX), a well-known P-gp substrate drug by the derivative. Compound 5c, the FA derivative chosen as a significant P-gp inhibitor among eight FA candidates by in vitro results, increased PTX AUCinf as much as twofold versus the control by reducing PTX elimination in rats. These results suggest that FA derivative can increase PTX bioavailability by inhibiting P-gp existing in eliminating organs.


2013 ◽  
Vol 106 ◽  
pp. 37-44 ◽  
Author(s):  
Ayako Furugen ◽  
Hiroaki Yamaguchi ◽  
Nobuaki Tanaka ◽  
Narumi Shiida ◽  
Jiro Ogura ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document